Not legal advice; educational only. Cases are described according to their public posture, and civil settlements resolve allegations without an admission of liability unless a court found otherwise.
In the companion pieces, I showed who has won whistleblower cases with public data and how to build the screen that finds the lead. This article is about everything that happens after the screen lights up, the part that takes three to seven years, that most cases do not survive, and that no dataset can do for you.
Read it as expectation-setting. A False Claims Act qui tam case is not a lottery ticket; it is a multi-year endurance test with a specific, knowable structure. Knowing that structure is the difference between a hobby and a plan, and it is the part a forensic practitioner can actually be paid to navigate.
What the False Claims Act gives a private citizen
The federal False Claims Act (31 U.S.C. §§ 3729, 3730) makes it illegal to knowingly submit a false claim for federal money, and its “qui tam” provision lets a private citizen, the relator, sue on the government’s behalf and share in the recovery. Two features give the statute its force, and you need both in your head before Stage 1:
- The money is asymmetric. A violator owes treble (triple) damages plus a civil penalty per false claim of \$14,308 to \$28,619 under the current inflation adjustment. Penalties stack per claim, so a scheme with thousands of invoices generates enormous exposure independent of actual damages.
- “Knowingly” is the whole ballgame. Under § 3729(b)(1), that means actual knowledge, deliberate ignorance, or reckless disregard, but an honest billing dispute or a good-faith reading of an ambiguous rule is not fraud. Your case lives or dies on evidence of a knowing falsehood.
The scale is real and at a record. In fiscal year 2025 the Justice Department recovered more than \$6.8 billion, the most in the law’s history, and whistleblowers were behind the overwhelming majority of it.
| FY2025 False Claims Act | Figure |
|---|---|
| Total recoveries | >\$6.8 billion (record) |
| Health-care-related | >\$5.7 billion |
| Qui tam (whistleblower) suits filed | 1,297 (record) |
| Recoveries from qui tam suits | >\$5.3 billion |
| Relator (whistleblower) awards paid | ~\$330 million |
Stage 1, Detection and evidence
The screen produces an outlier. A case requires a knowing false claim. Closing that gap is the work.
A viable lead is a specific, provable falsehood that caused the government to pay, billing for services not rendered, medically unnecessary volume, a false compliance certification, a kickback-tainted claim, made by someone who knew, or recklessly disregarded, that it was false. What moves an outlier toward that bar is corroboration the data cannot supply: documents, internal communications, a cooperating witness, the operative records. As the Integra Med Analytics dismissals taught the whole field, a statistic that is “consistent with both” fraud and lawful practice does not state a claim.
Two cautions belong in bold from the first day. Gather only what you can lawfully access, improperly taken records, especially privileged or patient-protected files, can damage the case and the relator. And first to file wins: under 31 U.S.C. § 3730(b)(5), only the first relator on a given fraud can recover, and public-data anomalies are reproducible by definition, so speed and confidentiality are strategic assets.
Stage 2, Counsel
You effectively cannot do this alone. Because the suit is brought on the government’s behalf, courts will not let a relator litigate it pro se, and the sealed-filing mechanics are not navigable without an experienced firm. The good news: reputable whistleblower firms work on contingency, no hourly fees, no retainer, and the Act lets a prevailing relator recover reasonable attorneys’ fees and costs from the defendant (§ 3730(d)), on top of the share, which is why the model works.
Expect to be vetted hard; most inquiries are declined. A firm is asking: is there a knowing false claim with strong, first-hand, documented evidence? Are the damages large enough to justify years of work? Any first-to-file or public-disclosure problem, and is the relator an “original source”? Is the relator a credible witness? Is this a government enforcement priority (health care, government contracts, cybersecurity)? Choosing the right firm, with the right relationship to the Justice Department and the stomach to litigate alone if the government declines, is part of what successful relators did.
Stage 3, Filing under seal
This is the procedural heart of the statute, and the part most people get wrong. Under 31 U.S.C. § 3730(b)(2), three things happen at once and in secret:
- The complaint is filed under seal (“in camera”), stays sealed for at least 60 days, and is not served on the defendant, who does not know it has been sued.
- The disclosure statement. The relator serves the government with “substantially all material evidence and information” they possess. This document, separate from, and far more detailed than, the complaint, is usually the most labor-intensive and most persuasive thing the relator’s side produces. It is where a forensic case is won or lost.
- Service on the United States, per the rules, to both the local U.S. Attorney and the Justice Department.
The seal exists so the government can investigate without tipping off the defendant or a parallel criminal inquiry.
Stage 4, The seal period and the government’s investigation
The “60 days” is a legal fiction. In practice the government moves for extensions, and courts routinely grant them; one to three years under seal is ordinary, longer in complex matters. During that time the U.S. Attorney’s Office works the case, issuing civil investigative demands for the defendant’s records, interviewing witnesses, retaining experts, quantifying damages, and coordinating with the defrauded agency (HHS-OIG, DCIS) and often a parallel criminal team.
For the relator, this is the long, quiet, anxious middle: you keep the entire matter secret, you cannot tell colleagues, cannot discuss it publicly, and frequently keep working alongside the target, for years, with no guarantee of anything.
Stage 5, The intervention decision
At the end of the seal, the government elects. It either intervenes, joins the case and brings its resources, subpoena power, and credibility, or declines, leaving the relator the right to proceed alone.
Intervention is the single biggest predictor of recovery; the overwhelming majority of recovered dollars come from intervened cases. Declination is not a ruling that the case lacks merit, it often reflects resources or priorities, but statistically, declined cases are much harder to win and recover far less. The trade-off runs the other way on the relator’s percentage, as Stage 7 explains: you are paid less for a case the government carried, and more for one you carried yourself.
Stage 6, Resolution
Most cases settle. Facing treble damages, per-claim penalties, and collateral consequences like exclusion from federal programs or suspension and debarment from contracting, defendants have strong reasons to resolve rather than try the case. If the government intervened, it leads the negotiation and the relator’s counsel advocates for the share; if it declined, the relator’s firm carries the full litigation, discovery, motions, experts, possibly trial, at its own cost and risk. Success usually looks like a settlement years later, not a courtroom verdict.
Stage 7, The relator’s share
Governed by 31 U.S.C. § 3730(d), this is the number to quote precisely:
| Scenario | Statutory relator’s share |
|---|---|
| Government intervenes | 15%, 25% of the recovery |
| Government declines; relator litigates | 25%, 30% of the recovery |
| Case based primarily on public disclosures | up to 10% |
| Relator planned or initiated the fraud | court may reduce; no floor |
| Relator convicted of the underlying fraud | dismissed; no share |
Where you land inside the band is not random. The Justice Department’s relator-share guidelines reward reporting promptly, trying to stop the fraud internally first, being an excellent, credible witness, and providing substantial, sustained assistance, the last of which is where a forensic contribution moves the needle. The share is a percentage of proceeds, and proceeds reflect treble damages plus per-claim penalties, which is why a multi-claim case can produce a very large check even at the 15% floor. Across FY2025, relator awards totaled roughly \$330 million.
Stage 8, Timeline, odds, and the honest toll
Plan for three to seven years, driven by the repeated seal extensions and the length of the investigation. The government intervenes in only a minority of qui tam cases, practitioners commonly estimate roughly one in five, yet those cases drive the large majority of dollars, so a realistic path to a meaningful recovery runs through either intervention or a strong, well-funded declined-case prosecution. (Treat the “one in five” as a practitioner rule of thumb; the Justice Department does not publish a single clean intervention rate.)
And the toll is real: years of secrecy, often spent working beside the wrongdoer; career disruption; financial and family strain; and no guaranteed payout. This is not a get-rich-quick path. It is a test of endurance with a contingent reward.
Stage 9, Protection against retaliation
The Act anticipates the obvious risk. Under 31 U.S.C. § 3730(h), an employee, contractor, or agent who is discharged, demoted, suspended, threatened, harassed, or otherwise discriminated against for lawful acts in furtherance of an FCA action is entitled to make-whole relief: reinstatement with seniority, two times back pay plus interest, and special damages including litigation costs and reasonable attorneys’ fees. This remedy is separate from the relator’s share and is available even if the underlying case is unsuccessful or the government declines, though the claim has a short window (generally three years), so it is not something to sit on.
Where the forensic skill set earns its keep
Notice where the leverage in this life cycle actually sits. It is not the anomaly score from Stage 1. It is the disclosure statement in Stage 3, the document that makes the government care enough to investigate, and the damages model that sizes the recovery in Stages 6 and 7. Both are forensic-accounting work, and both are exactly what a Certified Fraud Examiner is trained to produce.
The ACFE‘s Report to the Nations makes the point that should anchor the whole enterprise: tips, not analytics, catch the most occupational fraud, roughly three times as often as the next method. The whistleblower is the detection mechanism; the analytics merely aim it. A CFE’s contribution to a qui tam case is concrete and measurable: reconstruct the claims from the data, map the scheme onto the ACFE Fraud Tree so the right evidence gets gathered, quantify the treble-damages-and-penalties exposure, and assemble the § 3730(b) disclosure into something a line attorney at the Justice Department will act on. Done well, that work is also what pushes the relator’s share toward the top of the statutory band, because the government weighs how substantially the relator contributed.
That is the honest shape of it. The public-data screen finds the lead in an afternoon. This nine-stage process, and the discipline to build a real, particularized, knowingly-false-claim case on top of the lead, is what turns it into a recovery. The numbers find the lead; this is the work that makes the case. And if you sit on the other side of the table, buying a company that bills the government, the same map tells you what risk you are inheriting, which is the subject of Don’t Inherit the Fraud.
By Noah Green CPA CFE, for Sheepdog Prosperity Partners. Educational only; not legal advice and not a substitute for qualified whistleblower counsel.
Primary sources: 31 U.S.C. § 3729 · 31 U.S.C. § 3730 · DOJ, The False Claims Act · DOJ, FY2025 recoveries exceed \$6.8B · Anti-Fraud Coalition (TAF), relator share · Sidley, FCA civil penalty figures · ACFE, Report to the Nations · ACFE, Fraud Tree